RPG LIFE SCIENCES Q2 FY27 CONCALL: TARGETS ₹300–350 CR API REVENUE BY FY30 & ₹500 CR BY FY32; EXPECTS 25–30% API GROWTH CAGR, ACQUIRED PLANTS TO ADD ₹25–30 CR REVENUE IN H2 FY27 & DOMESTIC FORMULATIONS TO GROW ABOVE 1.5X MARKET